174,516 Shares in Select Medical Holdings Corporation $SEM Acquired by Carmignac Gestion

Carmignac Gestion purchased a new stake in Select Medical Holdings Corporation (NYSE:SEM) during the first quarter, HoldingsChannel reports. The firm purchased 174,516 shares of the health services provider’s stock, valued at approximately $2,843,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in SEM. Alpine Woods Capital Investors LLC bought a new position in shares of Select Medical in the first quarter valued at about $295,000. Segall Bryant & Hamill LLC boosted its holdings in shares of Select Medical by 65.3% during the 1st quarter. Segall Bryant & Hamill LLC now owns 281,857 shares of the health services provider’s stock worth $4,566,000 after buying an additional 111,329 shares during the period. Groupe la Francaise acquired a new position in Select Medical in the 1st quarter valued at about $4,602,000. Quantinno Capital Management LP raised its holdings in Select Medical by 19.2% in the 1st quarter. Quantinno Capital Management LP now owns 33,469 shares of the health services provider’s stock valued at $545,000 after acquiring an additional 5,384 shares during the period. Finally, Polar Asset Management Partners Inc. bought a new position in Select Medical in the 1st quarter valued at about $22,806,000. 89.48% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on SEM. Zacks Research upgraded Select Medical from a “strong sell” rating to a “hold” rating in a report on Monday, May 4th. Weiss Ratings upgraded Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, June 4th. Finally, Mizuho restated a “neutral” rating and issued a $16.50 price target (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. One equities research analyst has rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $15.50.

Select Medical Stock Performance

NYSE SEM opened at $16.51 on Monday. The firm has a 50-day moving average price of $16.54 and a two-hundred day moving average price of $16.19. Select Medical Holdings Corporation has a 12-month low of $11.65 and a 12-month high of $16.99. The company has a market capitalization of $2.05 billion, a P/E ratio of 15.58, a P/E/G ratio of 0.95 and a beta of 1.01. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.88.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.07). The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.44 earnings per share. Analysts anticipate that Select Medical Holdings Corporation will post 1.26 earnings per share for the current year.

Select Medical Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.